The latest T1D content
Research that matters
Our daily questions
Continue with Google
Continue with Facebook
Now enrolling adults with type 1 diabetes for a nighttime hypoglycemia study.
T1D Exchange is helping Zucara Therapeutics recruit for their Phase 2 clinical trial evaluating an investigational drug that may help adults living with type 1 diabetes (T1D) who experience nighttime lows.
New study locations have recently been added across the U.S., making participation easier. If you live near one of the following locations, you may now be eligible for this clinical trial, even if you were previously disqualified.
T1D Exchange is not a sponsor and is not administering this clinical trial, nor are we implying that you will qualify. We are sharing this research opportunity with you so you can decide whether to seek more information or participate.
CLINICAL TRIAL DETAILS
Zucara Therapeutics, Inc., is conducting a clinical trial to evaluate an investigational medication that may lower the risk of experiencing low glucose levels during the night.
This clinical trial will help determine how well ZT-01, an investigational drug, works in reducing nighttime hypoglycemia and the safety and tolerability of three dose levels of ZT-01 in adults with T1D.
Share this information with friends, family, or your doctor:
See if you qualify
Step 1: Complete a brief questionnaire to determine if you may be a good fit for this
clinical trial.
Step 2: If your answers in the eligibility screener suggest you may qualify, your local
study site coordinator will contact you. Your local study site coordinator will ask follow-
up questions to confirm your eligibility for this clinical trial. They will also provide
additional information about this research opportunity and, if you qualify, give you the
option to enroll.
To protect your privacy, we will not share your contact information with the study staff unless you sign the Informed Consent Form at the beginning of the eligibility questionnaire.
DIRECTORY OF SITES BY STATE
University of Southern California
Keck School of Medicine
Eastside Center for Diabetes
245 South Fetterly Ave
Suite 22
Los Angeles, CA 90022
Headlands Research- AMCR Institute
625 West Citracado Parkway
Escondido, CA 92025
Hanson Clinical Research Center Inc.
21216 Olean Blvd, Suite 6 & 7
Port Charlotte, FL 33952
Palm Beach Diabetes and Endocrine Specialists
Metabolic Research Institute
1515 North Flagler Dr
Suite 440
West Palm Beach, FL 33401
East Coast Institute for Research
8773 Perimeter Park Court
Jacksonville, FL 32216
East Coast Institute for Research
265 Sheraton Blvd, Suite 100
Macon, GA 31210
Indiana Health University Hospital
550 North University Blvd
Indianapolis, IN 46202
MedStar Good Samaritan Hospital
5601 Loch Raven Blvd, 2nd floor
Baltimore, MD 21239
Palm Medical Group / Palm Research Centre Inc
9280 West Sunset Rd
Suite 306
Las Vegas, NV 89148
Albany Medical Center – Albany Med Endocrinology
220 Washington Avenue Ext
Albany, NY 12203
Lucas Research, Inc.
623 North 35th Street
Morehead City, NC 28557
University Diabetes & Endocrine Consultants
5616 Brainerd Rd
Suite 208
Chattanooga, TN 37411
Texas Diabetes and Endocrinology – South Austin Office
5000 Davis Lane
Suite 200
Austin, TX 78749
Diabetes & Glandular Disease Clinic
5107 Medical Dr
San Antonio, TX 78229
Southern Endocrinology Associates
1621 North Belt Line Road
Suite A
Mesquite, TX 75149
North Texas Endocrine Center
9301 North Central Expressway
Suite 570, Tower II
Dallas, TX 75231
Diabetes & Endocrine Treatment Specialists
7410 S. Creek Road
Suite 100
Sandy, UT 84093
NOTE: This site is for US residents only. If you do not live in the United States and are located in Canada, please click on this link to learn more about how you may be able to participate in this trial.
WHAT TO EXPECT IF YOU ENROLL IN THE CLINICAL TRIAL
- Participation in the clinical trial will last approximately 16 weeks. During the trial, participants take subcutaneous injections with at least two weeks of no injections.
- The study requires six in-person visits and two phone calls over this period – approximately 16 weeks.
- The clinical trial research staff will communicate other requirements.
- Qualified participants will receive payment for time and travel.
Share this study
